medroxyprogesterone | Provera tablets 500 mg 30 pcs.
Special Price
$64.02
Regular Price
$74.00
In stock
SKU
BID496455
Latin name
PROVERA
PROVERA
Latin name
PROVERA
Release form
Tablets.
Packaging
In a blister pack of 10 tablets. There are 3 blisters in the package.
Indications
For use in gynecology:
contraception
endometriosis.
For use in oncology:
additional and palliative treatment of recurrent and metastatic endometrial cancer or kidney cancer
palliative treatment for hormone-dependent forms of recurrent breast cancer in postmenopausal women
prostate carcinoma, some forms of prostate adenoma
carcinoma cancer.
Contraindications
Pregnancy
hypersensitivity to medroxyprogesterone.
Use during pregnancy and lactation
Contraindicated in pregnancy.
Does not affect lactation. It is excreted in breast milk in an insignificant amount, while there are no negative phenomena in the development of children receiving this milk.
Composition
1 tablet contains:
Active ingredient: medroxyprogesterone (in the form of acetate) 500 mg.
Excipients: corn starch magnesium stearate MCC gelatin polyethylene glycol 400 sodium starch docusate sodium (85%) with sodium benzoate (15%).
Dosage and administration
Set individually, depending on the indications, stage of the disease, treatment regimen.
Side effects
From the side of the central nervous system: headache, irritability, sleep disturbances, drowsiness, feeling tired, depression, dizziness.
From the digestive system: nausea.
Allergic reactions: urticaria, pruritus, rash, anaphylactoid reactions.
From the hematopoietic system: thromboembolic disorders.
From the endocrine system: increased sensitivity of the mammary gland, galactorrhea, erosion and a change in the secretion of the cervix. When used at a dose of 500 mg / day or more, acne, hirsutism, weight gain, a moon-shaped face are possible.
Other: hyperthermia.
ЛРкарствРнноРвзаимодРйствимbr>
При одноврРмРнном примРнРнии с аминоглутРтимидом возможно умРньшРниРконцРнтрации мРдроксипрогРстРрона в плазмРкрови.
При одноврРмРнном примРнРнии с прРпаратами, в з вающими индукцию микросомальн х фРрмРнтов пРчРни возможно умРньшРниРконтрацРптивного дРйствия мРдроксипрогРстРрона при парРнтРральном примРнРнии.
КарбамазРпин, гризРофульвин, фРнобарбитал, фРнитоин, рифампицин могут пов шать клирРнс гРстагРнов (прогРстагРнов).
ГРстагРн (прогРстагРн ) могут измРнять эффРктивность гипогликРмичРских прРпаратов.
ГРстагРн (прогРстагРн ) могут ингибировать мРтаболизм циклоспорина, что приводит к увРличРнию Рго концРнтрации в плазмРкрови и пов шРнию риска токсичности.
Storage Conditions
Store at 15-30 РC.
Shelf life
5 years.
Terms and conditions otpuska from drugstores
prescription
dosage form
tablets
Possible product names
CHECKS 0.5 N30 TABLE
Checks 500mg Tab. X30 (R)
CHECK TAB. 500MG No. 30
CHECK TAB. 500MG N30
Provera tablets 500 mg 30 pcs.
PROVERA
Release form
Tablets.
Packaging
In a blister pack of 10 tablets. There are 3 blisters in the package.
Indications
For use in gynecology:
contraception
endometriosis.
For use in oncology:
additional and palliative treatment of recurrent and metastatic endometrial cancer or kidney cancer
palliative treatment for hormone-dependent forms of recurrent breast cancer in postmenopausal women
prostate carcinoma, some forms of prostate adenoma
carcinoma cancer.
Contraindications
Pregnancy
hypersensitivity to medroxyprogesterone.
Use during pregnancy and lactation
Contraindicated in pregnancy.
Does not affect lactation. It is excreted in breast milk in an insignificant amount, while there are no negative phenomena in the development of children receiving this milk.
Composition
1 tablet contains:
Active ingredient: medroxyprogesterone (in the form of acetate) 500 mg.
Excipients: corn starch magnesium stearate MCC gelatin polyethylene glycol 400 sodium starch docusate sodium (85%) with sodium benzoate (15%).
Dosage and administration
Set individually, depending on the indications, stage of the disease, treatment regimen.
Side effects
From the side of the central nervous system: headache, irritability, sleep disturbances, drowsiness, feeling tired, depression, dizziness.
From the digestive system: nausea.
Allergic reactions: urticaria, pruritus, rash, anaphylactoid reactions.
From the hematopoietic system: thromboembolic disorders.
From the endocrine system: increased sensitivity of the mammary gland, galactorrhea, erosion and a change in the secretion of the cervix. When used at a dose of 500 mg / day or more, acne, hirsutism, weight gain, a moon-shaped face are possible.
Other: hyperthermia.
ЛРкарствРнноРвзаимодРйствимbr>
При одноврРмРнном примРнРнии с аминоглутРтимидом возможно умРньшРниРконцРнтрации мРдроксипрогРстРрона в плазмРкрови.
При одноврРмРнном примРнРнии с прРпаратами, в з вающими индукцию микросомальн х фРрмРнтов пРчРни возможно умРньшРниРконтрацРптивного дРйствия мРдроксипрогРстРрона при парРнтРральном примРнРнии.
КарбамазРпин, гризРофульвин, фРнобарбитал, фРнитоин, рифампицин могут пов шать клирРнс гРстагРнов (прогРстагРнов).
ГРстагРн (прогРстагРн ) могут измРнять эффРктивность гипогликРмичРских прРпаратов.
ГРстагРн (прогРстагРн ) могут ингибировать мРтаболизм циклоспорина, что приводит к увРличРнию Рго концРнтрации в плазмРкрови и пов шРнию риска токсичности.
Storage Conditions
Store at 15-30 РC.
Shelf life
5 years.
Terms and conditions otpuska from drugstores
prescription
dosage form
tablets
Possible product names
CHECKS 0.5 N30 TABLE
Checks 500mg Tab. X30 (R)
CHECK TAB. 500MG No. 30
CHECK TAB. 500MG N30
Provera tablets 500 mg 30 pcs.
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review